Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib

C Lin, Z Ren, XI Yang, R Yang, Y Chen, Z Liu, Z Dai… - Cancer letters, 2020 - Elsevier
Understanding the molecular mechanisms regulating tumor dissemination and therapeutic
resistance is of central importance for effective cancer therapies. Here, we report that nerve …
被引用次数：46 相关文章

Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib

C Lin, Z Ren, X Yang, R Yang, Y Chen, Z Liu, Z Dai… - Cancer Letters, 2020 - elibrary.ru
Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT
and confers resistance to the EGFR inhibitor erlotinib КОРЗИНА ПОИСК НАВИГАТОР …

Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib.

C Lin, Z Ren, X Yang, R Yang, Y Chen, Z Liu, Z Dai… - Cancer Letters, 2019 - europepmc.org
Understanding the molecular mechanisms regulating tumor dissemination and therapeutic
resistance is of central importance for effective cancer therapies. Here, we report that nerve …

[引用][C] Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib

C Lin, Z Ren, X Yang, R Yang, Y Chen, Z Liu, Z Dai… - Cancer Letters, 2020 - cir.nii.ac.jp
Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers
EMT and confers resistance to the EGFR inhibitor erlotinib | CiNii Research CiNii 国立情報学 …

Nerve growth factor (NGF)-TrkA axis in head and neck squamous cell carcinoma triggers EMT and confers resistance to the EGFR inhibitor erlotinib

C Lin, Z Ren, X Yang, R Yang, Y Chen… - Cancer …, 2020 - pubmed.ncbi.nlm.nih.gov
Understanding the molecular mechanisms regulating tumor dissemination and therapeutic
resistance is of central importance for effective cancer therapies. Here, we report that nerve …